Details for New Drug Application (NDA): 214971
✉ Email this page to a colleague
The generic ingredient in SODIUM NITROPRUSSIDE is sodium nitroprusside. There are one thousand four hundred and seventy-two drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the sodium nitroprusside profile page.
Summary for 214971
Tradename: | SODIUM NITROPRUSSIDE |
Applicant: | Be Pharms |
Ingredient: | sodium nitroprusside |
Patents: | 0 |
Pharmacology for NDA: 214971
Physiological Effect | Vasodilation |
Suppliers and Packaging for NDA: 214971
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SODIUM NITROPRUSSIDE | sodium nitroprusside | INJECTABLE;INJECTION | 214971 | ANDA | BE Pharmaceuticals Inc. | 71839-120 | 71839-120-01 | 1 VIAL in 1 CARTON (71839-120-01) / 2 mL in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 25MG/ML | ||||
Approval Date: | Jul 12, 2021 | TE: | AP | RLD: | No |
Complete Access Available with Subscription